DR. BRIAN WALLACE CHRISTMAN, M.D.
Osteopathic Medicine at 24 Ave, Nashville, TN
License number
Tennessee MD0000016603
Category
Osteopathic Medicine
Type
Pulmonary Disease
Address
Address
1310 24Th Ave S MEDICAL SERVICE 111, Nashville, TN 37212
Phone
(615) 327-5349
(615) 321-6327 (Fax)
(615) 321-6327 (Fax)
Personal information
See more information about BRIAN WALLACE CHRISTMAN at radaris.comName
Address
Phone
1713 Temple Ave, Nashville, TN 37215
1713 Temple Ave, Nashville, TN 37215
Professional information
See more information about BRIAN WALLACE CHRISTMAN at trustoria.com
Professor And Vice-Chair/Medicine At Vanderbilt University Medical Center
Professor And Vice-Chair/Medicine At Vanderbilt University Medical Center
Position:
Professor and Vice-Chair/Medicine at Vanderbilt University Medical Center, Chief, Medical Service at VA Tenn Valley Health Care System, Associate Director, Residency Program in Internal Medicine at Vanderbilt University
Location:
Nashville, Tennessee
Industry:
Higher Education
Work:
Vanderbilt University Medical Center
since Sep 2003
-
Professor and Vice-Chair/Medicine
VA Tenn Valley Health Care System
- Greater Nashville Area of Middle TN since Sep 2003
-
Chief, Medical Service
Vanderbilt University
- Nashville, TN since Sep 2003
-
Associate Director, Residency Program in Internal Medicine
Vanderbilt University
Jul 2010 - Jun 2011
-
Chair, Faculty Senate
Vanderbilt University
Jul 1987 - Sep 2003
-
Asst. and Associate Professor of Medicine
Education:
University of Oklahoma College of Medicine 1977 - 1981
M.D., Medicine Tulane University 1973 - 1977
B.S., Biochemistry
M.D., Medicine Tulane University 1973 - 1977
B.S., Biochemistry
Skills:
Cell Culture, Clinical Research, Cell Biology, Biochemistry, Immunohistochemistry, Science, Animal Models, Healthcare
Brian Wallace Christman, Nashville TN
Brian Wallace Christman, Nashville TN
Specialties:
Pulmonologist
Address:
1310 24Th Ave S, Nashville, TN 37212
Education:
University of Oklahoma, College of Medicine - Doctor of Medicine
Vanderbilt University Medical Center - Fellowship - Pulmonary Disease (Internal Medicine)
Vanderbilt University Medical Center - Residency - Family Medicine
Vanderbilt University Medical Center - Fellowship - Pulmonary Disease (Internal Medicine)
Vanderbilt University Medical Center - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Critical Care Medicine (Internal Medicine), American Board of Internal Medicine Sub-certificate in Pulmonary Disease (Internal Medicine)
Dr. Brian W Christman, Nashville TN - MD (Doctor of Medicine)
Dr. Brian W Christman, Nashville TN - MD (Doctor of Medicine)
Specialties:
Critical Care Medicine, Pulmonology
Address:
1310 24Th Ave S, Nashville 37212
(615) 327-4751 (Phone), (615) 873-7743 (Fax)
T1219 Mcn, Nashville 37232
(615) 327-5349 (Phone)
HEALTHSTAR PHYSICIANS, P.C.
420 W Morris Blvd SUITE 400D, Morristown 37813
(423) 586-7509 (Phone), (423) 581-5701 (Fax)
(615) 327-4751 (Phone), (615) 873-7743 (Fax)
T1219 Mcn, Nashville 37232
(615) 327-5349 (Phone)
HEALTHSTAR PHYSICIANS, P.C.
420 W Morris Blvd SUITE 400D, Morristown 37813
(423) 586-7509 (Phone), (423) 581-5701 (Fax)
Certifications:
Critical Care Medicine, 1989, Internal Medicine, 1984, Pulmonary Disease, 1986
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1310 24Th Ave S, Nashville 37212
T1219 Mcn, Nashville 37232
HEALTHSTAR PHYSICIANS, P.C.
420 W Morris Blvd SUITE 400D, Morristown 37813
Vanderbilt University Hospital
1211 Medical Center Dr, Nashville 37232
T1219 Mcn, Nashville 37232
HEALTHSTAR PHYSICIANS, P.C.
420 W Morris Blvd SUITE 400D, Morristown 37813
Vanderbilt University Hospital
1211 Medical Center Dr, Nashville 37232
Education:
Medical School
University of Oklahoma / Health Sciences Center
Graduated: 1981
Vanderbilt University Hospital
Vanderbilt University
University of Oklahoma / Health Sciences Center
Graduated: 1981
Vanderbilt University Hospital
Vanderbilt University
Therapeutic Methods Relating To Human Carbamyl Phosphate Synthetase I Polymorphism
Therapeutic Methods Relating To Human Carbamyl Phosphate Synthetase I Polymorphism
US Patent:
6743823, Jun 1, 2004
Filed:
Jun 1, 2000
Appl. No.:
09/585077
Inventors:
Marshall L. Summar - Brentwood TN
Brian W. Christman - Nashville TN
Brian W. Christman - Nashville TN
Assignee:
Vanderbilt University - Nashville TN
International Classification:
A61K 31195
US Classification:
514565, 536 232, 536 235, 435 6, 435194
Abstract:
Isolated polynucleotide molecules and peptides encoded by these molecules are used in the analysis of human carbamyl phosphate synthetase I phenotypes, as well as in diagnostic and therapeutic applications, relating to a human carbamyl phosphate synthetase I polymorphism. By analyzing genomic DNA or amplified genomic DNA, or amplified cDNA derived from mRNA, it is possible to type a human carbamyl phosphate synthetase I with regard to the human carbamyl phosphate synthetase I polymorphism, for example, in the context of diagnosing and treating hepatic veno-occlusive disease (HVOD) associated with bone marrow transplants.
Human Carbamyl Phosphate Synthetase I Polymorphism And Diagnostic Methods Related Thereto
Human Carbamyl Phosphate Synthetase I Polymorphism And Diagnostic Methods Related Thereto
US Patent:
6346382, Feb 12, 2002
Filed:
Jun 1, 1999
Appl. No.:
09/323472
Inventors:
Marshall L. Summar - Brentwood TN
Brian W. Christman - Nashville TN
Brian W. Christman - Nashville TN
Assignee:
Vanderbilt University - Nashville TN
International Classification:
C12Q 168
US Classification:
435 6, 435 912, 435 915, 536 232, 536 235, 536 2431, 536 2433, 536 2532
Abstract:
Isolated polynucleotide molecules and peptides encoded by these molecules are used in the analysis of human carbamyl phosphate synthetase I phenotypes, as well as in diagnostic and therapeutic applications, relating to a human carbamyl phosphate synthetase I polymorphism. By analyzing genomic DNA or amplified genomic DNA, or amplified cDNA derived from mRNA, it is possible to type a human carbamyl phosphate synthetase I with regard to the human carbamyl phosphate synthetase I polymorphism, for example, in the context of diagnosing and treating hepatic veno-occlusive disease (HVOD) associated with bone marrow transplants.
Therapeutic Methods Employing Nitric Oxide Precursors
Therapeutic Methods Employing Nitric Oxide Precursors
US Patent:
2004023, Nov 25, 2004
Filed:
Feb 24, 2004
Appl. No.:
10/785374
Inventors:
Marshall Summar - Brentwood TN, US
Brian Christman - Nashville TN, US
Frederick Barr - Nashville TN, US
Brian Christman - Nashville TN, US
Frederick Barr - Nashville TN, US
Assignee:
Vanderbilt University
International Classification:
A61K031/198
US Classification:
514/565000
Abstract:
Isolated polynucleotide molecules and peptides encoded by these molecules are used in the analysis of human carbamyl phosphate synthetase I phenotypes, as well as in diagnostic and therapeutic applications, relating to a human carbamyl phosphate synthetase I polymorphism. By analyzing genomic DNA or amplified genomic DNA, or amplified cDNA derived from mRNA, it is possible to type a human carbamyl phosphate synthetase I with regard to the human carbamyl phosphate synthetase I polymorphism, for example, in the context of diagnosing and treating hepatic veno-occlusive disease (HVOD) associated with bone marrow transplants.
Therapeutic Methods Employing Nitric Oxide Precursors
Therapeutic Methods Employing Nitric Oxide Precursors
US Patent:
8536225, Sep 17, 2013
Filed:
Apr 25, 2012
Appl. No.:
13/456014
Inventors:
Marshall L. Summar - Brentwood TN, US
Brian W. Christman - Nashville TN, US
Frederick E. Barr - Nashville TN, US
Brian W. Christman - Nashville TN, US
Frederick E. Barr - Nashville TN, US
Assignee:
Vanderbilt University - Nashville TN
International Classification:
A61K 31/195
US Classification:
514565
Abstract:
Isolated polynucleotide molecules and peptides encoded by these molecules are used in the analysis of human carbamyl phosphate synthetase I phenotypes, as well as in diagnostic and therapeutic applications, relating to a human carbamyl phosphate synthetase I polymorphism. By analyzing genomic DNA or amplified genomic DNA, or amplified cDNA derived from mRNA, it is possible to type a human carbamyl phosphate synthetase I with regard to the human carbamyl phosphate synthetase I polymorphism, for example, in the context of diagnosing and treating hepatic veno-occlusive disease (HVOD) associated with bone marrow transplants.
Therapeutic Methods Employing Nitric Oxide Precursors
Therapeutic Methods Employing Nitric Oxide Precursors
US Patent:
8188147, May 29, 2012
Filed:
May 16, 2008
Appl. No.:
12/122117
Inventors:
Marshall L. Summar - Brentwood TN, US
Brian W. Christman - Nashville TN, US
Frederick E. Barr - Nashville TN, US
Brian W. Christman - Nashville TN, US
Frederick E. Barr - Nashville TN, US
Assignee:
Vanderbilt University - Nashville TN
International Classification:
A61K 31/195
US Classification:
514565
Abstract:
Isolated polynucleotide molecules and peptides encoded by these molecules are used in the analysis of human carbamyl phosphate synthetase I phenotypes, as well as in diagnostic and therapeutic applications, relating to a human carbamyl phosphate synthetase I polymorphism. By analyzing genomic DNA or amplified genomic DNA, or amplified cDNA derived from mRNA, it is possible to type a human carbamyl phosphate synthetase I with regard to the human carbamyl phosphate synthetase I polymorphism, for example, in the context of diagnosing and treating hepatic veno-occlusive disease (HVOD) associated with bone marrow transplants.